Back to search

HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non–Small-Cell Lung Cancer

Data up to Jan 2025

Published2007
Citations48
References34

Total Citations Per Year

Abstract

References (34)

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

1999 • 1,501 citations

Basic Clinical Radiobiology

2009 • 1,072 citations

Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer

2000 • 635 citations

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial

1999 • 486 citations

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

2005 • 482 citations

Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma

2005 • 445 citations

Stereotactic Body Radiation Therapy in Multiple Organ Sites

2007 • 426 citations

Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial

2001 • 324 citations

A new approach to dose escalation in non–small-cell lung cancer

2001 • 251 citations

Basic Clinical Radiobiology

2010 • 232 citations

Selective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study

2005 • 211 citations

High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial

2002 • 205 citations

Final results of a Phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapy

2006 • 204 citations

Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets

2005 • 202 citations

Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer

2002 • 194 citations

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?

1998 • 167 citations

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial

2004 • 152 citations

Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer

1999 • 123 citations

Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study

2006 • 112 citations

Routine individualised patient dosimetry using electronic portal imaging devices

2007 • 106 citations

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

2000 • 77 citations

Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer

2003 • 72 citations

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

1998 • 65 citations

Radiation myelopathy

1998 • 60 citations

From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome

2002 • 56 citations

The late effects of toxicity scoring

1988 • 55 citations

Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy

2004 • 53 citations

Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report

1994 • 35 citations

Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis

2006 • 33 citations

Dose-escalation with CHARTWEL (Continuous Hyperfractionated Accelerated Radiotherapy Week-End Less) Combined with Neo-adjuvant Chemotherapy in the Treatment of Locally Advanced Non-small Cell Lung Cancer

2002 • 29 citations

Dose-volume effects in rat thoracolumbar spinal cord: An evaluation of NTCP models

2004 • 25 citations

International Clinical Trials in Radiation Oncology. The late effects of toxicity scoring.

1988 • 21 citations

Toxicity and outcome of a phase II trial of taxane‐based neoadjuvant chemotherapy and 3‐dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer

2006 • 14 citations

Cited By (0)

Loading...
HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated… (2007) – International Journal of Radiation Oncology*Biology*Physics | Metascience Observatory Explorer